Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis
暂无分享,去创建一个
Lois E. H. Smith | J. Sangiovanni | E. Chew | J. Kang | C. Serhan | A. Hellstrom | K. Connor | C. Aderman | A. Higuchi | Sharon F Majchrzak | D. Carper | Chatarina Lofqvist | Jing Chen | Song Hong | Elke A. Pravda | N. Salem
[1] D. Goukassian,et al. Neovascularization Receptor P75 Is Required in Ischemia-induced Α Tumor Necrosis Factor- Tumor Necrosis Factor-␣ Receptor P75 Is Required in Ischemia-induced Neovascularization , 2007 .
[2] Michael I Dorrell,et al. Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. , 2006, The Journal of clinical investigation.
[3] Katherine B Percarpio,et al. Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. , 2006, Chemistry & biology.
[4] J. Duffield,et al. Resolvin D Series and Protectin D1 Mitigate Acute Kidney Injury1 , 2006, The Journal of Immunology.
[5] M. Leduc,et al. Potential role of microglia in retinal blood vessel formation. , 2006, Investigative ophthalmology & visual science.
[6] John Savill,et al. Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.
[7] S. Germain,et al. Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1–dependent microvascular degeneration , 2005, Nature Medicine.
[8] Y. Yoon,et al. The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A. , 2005, The Journal of clinical investigation.
[9] Makoto Arita,et al. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[10] Charles N. Serhan,et al. Molecular circuits of resolution: formation and actions of resolvins and protectins , 2005, The Journal of Immunology.
[11] T. Shavlakadze,et al. Silencing TNFα activity by using Remicade or Enbrel blocks inflammation in whole muscle grafts: an in vivo bioassay to assess the efficacy of anti-cytokine drugs in mice , 2005, Cell and Tissue Research.
[12] A. Sher,et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 , 2005, The Journal of experimental medicine.
[13] Alan W. Stitt,et al. Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. , 2005, The American journal of pathology.
[14] J. Sangiovanni,et al. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina , 2005, Progress in Retinal and Eye Research.
[15] Charles N. Serhan,et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers , 2004, Lipids.
[16] P. Mukherjee,et al. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Kang,et al. Transgenic mice: Fat-1 mice convert n-6 to n-3 fatty acids , 2004, Nature.
[18] P. Mukherjee,et al. Neuroprotectin D 1 : A docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress , 2004 .
[19] W. Forssmann,et al. Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23 , 2003, FEBS letters.
[20] C. Serhan,et al. Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells , 2003, The Journal of Biological Chemistry.
[21] J. Kutok,et al. Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4). , 2002, The Journal of pharmacology and experimental therapeutics.
[22] Hee-Yong Kim,et al. Mechanisms of action of docosahexaenoic acid in the nervous system , 2001, Lipids.
[23] Richard A. Flavell,et al. Inhibition of NF-κB Activity and Enhancement of Apoptosis by the Neuropeptide Calcitonin Gene-related Peptide* , 2000, The Journal of Biological Chemistry.
[24] R. Sherwin,et al. Inhibition of NF- k B Activity and Enhancement of Apoptosis by the Neuropeptide Calcitonin Gene-related Peptide* , 2000 .
[25] K. Costeloe,et al. Are deficits of arachidonic and docosahexaenoic acids responsible for the neural and vascular complications of preterm babies? , 1997, The American journal of clinical nutrition.
[26] L. Aiello,et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[27] Lois E. H. Smith,et al. Oxygen-induced retinopathy in the mouse. , 1994, Investigative ophthalmology & visual science.
[28] P. Vassalli,et al. The pathophysiology of tumor necrosis factors. , 1992, Annual review of immunology.
[29] P. Baeuerle,et al. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B , 1990, Molecular and cellular biology.
[30] S. Fliesler,et al. Chemistry and metabolism of lipids in the vertebrate retina. , 1983, Progress in lipid research.